|
A biomaterials viewpoint for the 2020 SARS-CoV-2 vaccine development
|
. |
Figure 3.. Summary of SARS-CoV-2 vaccine types. A summary of several of the major vaccine types being manufactured, including live attenuated (A), inactivated (B, C), viral vector (D), bacterial vector (E), virus-like particles (F), DNA- or RNA-based (G), recombinant protein subunit (H), and synthetic peptides vaccines (I). Figure reprinted from Liu et al. |
![]() |